HUE044678T2 - Eljárás (4S)-4-(4-ciano-2-metoxifenil)-5-etoxi-2,8-dimetil-1,4-dihidro-1,6-naftiridin-3-karboxamid elõállítására és (4S)-4-(4-ciano-2-metoxifenil)-5-etoxi- 2,8-dimetil-1,4-dihidro-1-6-naftiridin-3-karboxamid visszanyerésére elektrokémiai módszerekkel - Google Patents

Eljárás (4S)-4-(4-ciano-2-metoxifenil)-5-etoxi-2,8-dimetil-1,4-dihidro-1,6-naftiridin-3-karboxamid elõállítására és (4S)-4-(4-ciano-2-metoxifenil)-5-etoxi- 2,8-dimetil-1,4-dihidro-1-6-naftiridin-3-karboxamid visszanyerésére elektrokémiai módszerekkel

Info

Publication number
HUE044678T2
HUE044678T2 HUE16753390A HUE044678T2 HU E044678 T2 HUE044678 T2 HU E044678T2 HU E16753390 A HUE16753390 A HU E16753390A HU E044678 T2 HUE044678 T2 HU E044678T2
Authority
HU
Hungary
Prior art keywords
naphthyridine
carboxamide
methoxyphenyl
dihydro
ethoxy
Prior art date
Application number
Other languages
English (en)
Inventor
Johannes Platzek
Kathrin Gottfried
Jens Assmann
Giulio Lolli
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of HUE044678T2 publication Critical patent/HUE044678T2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B15/00—Operating or servicing cells
    • C25B15/08—Supplying or removing reactants or electrolytes; Regeneration of electrolytes
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B15/00—Operating or servicing cells
    • C25B15/08—Supplying or removing reactants or electrolytes; Regeneration of electrolytes
    • C25B15/083—Separating products
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00—Electrolytic production of organic compounds
    • C25B3/01—Products
    • C25B3/05—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00—Electrolytic production of organic compounds
    • C25B3/01—Products
    • C25B3/07—Oxygen containing compounds
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00—Electrolytic production of organic compounds
    • C25B3/01—Products
    • C25B3/09—Nitrogen containing compounds
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00—Electrolytic production of organic compounds
    • C25B3/20—Processes
    • C25B3/23—Oxidation
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00—Electrolytic production of organic compounds
    • C25B3/20—Processes
    • C25B3/25—Reduction

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Metallurgy (AREA)
  • Materials Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HUE16753390 2015-08-21 2016-08-18 Eljárás (4S)-4-(4-ciano-2-metoxifenil)-5-etoxi-2,8-dimetil-1,4-dihidro-1,6-naftiridin-3-karboxamid elõállítására és (4S)-4-(4-ciano-2-metoxifenil)-5-etoxi- 2,8-dimetil-1,4-dihidro-1-6-naftiridin-3-karboxamid visszanyerésére elektrokémiai módszerekkel HUE044678T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15182042 2015-08-21
EP15182040 2015-08-21

Publications (1)

Publication Number Publication Date
HUE044678T2 true HUE044678T2 (hu) 2019-11-28

Family

ID=56694167

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE16753390 HUE044678T2 (hu) 2015-08-21 2016-08-18 Eljárás (4S)-4-(4-ciano-2-metoxifenil)-5-etoxi-2,8-dimetil-1,4-dihidro-1,6-naftiridin-3-karboxamid elõállítására és (4S)-4-(4-ciano-2-metoxifenil)-5-etoxi- 2,8-dimetil-1,4-dihidro-1-6-naftiridin-3-karboxamid visszanyerésére elektrokémiai módszerekkel

Country Status (30)

Country Link
US (1) US10392384B2 (hu)
EP (1) EP3337801B1 (hu)
JP (1) JP6843120B2 (hu)
KR (1) KR102677034B1 (hu)
CN (1) CN108137587B (hu)
AU (1) AU2016311135C1 (hu)
CA (1) CA2995949A1 (hu)
CL (1) CL2018000426A1 (hu)
CO (1) CO2018001759A2 (hu)
DK (1) DK3337801T3 (hu)
ES (1) ES2739907T3 (hu)
HR (1) HRP20191476T1 (hu)
HU (1) HUE044678T2 (hu)
IL (1) IL257522B (hu)
JO (1) JOP20160185B1 (hu)
LT (1) LT3337801T (hu)
MX (1) MX367959B (hu)
NZ (1) NZ739993A (hu)
PE (1) PE20180555A1 (hu)
PL (1) PL3337801T3 (hu)
PT (1) PT3337801T (hu)
RS (1) RS59086B1 (hu)
RU (1) RU2715226C2 (hu)
SG (1) SG11201801378VA (hu)
SI (1) SI3337801T1 (hu)
TW (1) TWI725044B (hu)
UA (1) UA124418C2 (hu)
UY (1) UY36863A (hu)
WO (1) WO2017032678A1 (hu)
ZA (1) ZA201801867B (hu)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3560922A1 (de) 2018-04-24 2019-10-30 Bayer Aktiengesellschaft Verfahren zur herstellung von (4s)- 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carbox-amid durch racemat-spaltung mittels diastereomerer weinsäureester
US12351557B2 (en) * 2018-12-24 2025-07-08 Eustralis Pharmaceuticals Limited Chemical compound manufacture, new salt form, and therapeutic uses thereof
CN110195239B (zh) * 2019-04-15 2020-08-14 浙江工业大学 一种多氯甲基吡啶衍生物电化学脱氯制备醛、酸的方法
CN110195238B (zh) * 2019-04-15 2020-08-14 浙江工业大学 一种三氯甲基吡啶衍生物电化学脱氯制备酰胺的方法
CN111910206B (zh) * 2019-05-07 2023-03-10 中国科学技术大学 一种合成3-氰基取代的咪唑并[1,5-a]喹啉类化合物的方法
AU2020295365A1 (en) * 2019-06-21 2022-01-06 Xerion Advanced Battery Corp. Methods for extracting lithium from spodumene
JP7714534B2 (ja) * 2019-10-17 2025-07-29 バイエル アクチェンゲゼルシャフト ジアステレオマー酒石酸エステルによるラセミ体分離により２－シアノエチル（４ｓ）－４－（４－シアノ－２－メトキシフェニル）－５－ヒドロキシ－２，８－ジメチル－１，４－ジヒドロ－１，６－ナフチリジン－３－カルボキシレートを調製する方法
US12365679B2 (en) * 2019-10-17 2025-07-22 Bayer Aktiengesellschaft Process for producing acyloxymethyl esters of (4S)-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carboxylic acid
JP7746261B2 (ja) 2019-10-17 2025-09-30 バイエル アクチェンゲゼルシャフト （４ｒ，４ｓ）－４－（４－シアノ－２－メトキシフェニル）－５－エトキシ－２，８－ジメチル－１，４－ジヒドロ－１，６－ナフチリジン－３－カルボキサミドを製造するための光化学法
CA3158166A1 (en) * 2019-10-17 2021-04-22 Bayer Aktiengesellschaft Process for the preparation of 2-cyanoethyl (4s)-4-(4-cyano-2-methoxy-phenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylate by resolution of racemates by means of diastereomeric tartaric acid esters
WO2021254896A1 (en) 2020-06-16 2021-12-23 Bayer Aktiengesellschaft Process for preparing (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide enabled by a catalytic asymmetric hantzsch ester reduction
CN113214248B (zh) * 2021-04-13 2022-04-26 湖南南新制药股份有限公司 一种1,4-二氢-1,6-萘啶衍生物、药物组合物及其用途
CN113897631B (zh) * 2021-10-24 2023-05-09 昆明学院 电化学合成吡啶-2-酮衍生物的方法
CN114149427A (zh) * 2021-12-18 2022-03-08 上海鼎雅药物化学科技有限公司 非奈利酮及其中间体的合成方法
CN115340539B (zh) 2022-01-19 2024-02-27 奥锐特药业股份有限公司 制备非奈利酮及其中间体的方法
CN114605410B (zh) * 2022-04-06 2023-12-29 浙江科聚生物医药有限公司 一种非奈利酮原料药的制备方法
EP4511365A1 (en) 2022-04-18 2025-02-26 Teva Pharmaceuticals International GmbH Processes for the preparation of finerenone
CN117304067A (zh) * 2022-06-21 2023-12-29 南京工业大学 一种非奈利酮中间体4-氰基-2-甲氧基苯甲醛的合成方法
CN115583866A (zh) * 2022-08-30 2023-01-10 上海厚博生物科技有限公司 一种用非奈利酮对映体制备非奈利酮的方法
JP2025540859A (ja) * 2022-12-16 2025-12-16 バイエル アクチェンゲゼルシャフト ４－（４－シアノ－２－メトキシフェニル）－５－エトキシ－２，８－ジメチル－１，４－ジヒドロ－１，６－ナフチリジン－３－カルボキサミドを調製するための逐次ワンポット合成
CN117945947A (zh) * 2024-01-26 2024-04-30 江西凯信生物医药有限公司 一种2-甲氧基-4-氰基苯甲醛的合成方法
CN119684288B (zh) * 2024-12-18 2026-04-17 中山百盛生物技术有限公司 非奈利酮的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3431303A1 (de) * 1984-08-25 1986-02-27 Goedecke Ag 1,6-naphthyridin-derivate, verfahren zu deren herstellung und deren verwendung
IL75987A (en) * 1984-08-25 1991-07-18 Goedecke Ag Tri-and tetrasubstituted-1,4-dihydro-1,6-naphthyridine-3-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
JP2009501199A (ja) 2005-07-12 2009-01-15 グラクソ グループ リミテッド Ｇｐｒ３８アゴニストとしてのピペラジンヘテロアリール誘導体
DE102006026583A1 (de) 2006-06-07 2007-12-13 Bayer Healthcare Aktiengesellschaft Aryl-substituierte hetero-bicyclische Verbindungen und ihre Verwendung
DE102007009494A1 (de) * 2007-02-27 2008-08-28 Bayer Healthcare Ag Substituierte 4-Aryl-1, 4-dihydro-1,6-naphthyridinamide und ihre Verwendung
DE102007061764A1 (de) * 2007-12-20 2009-06-25 Bayer Healthcare Ag Anellierte Cyanopyridine und ihre Verwendung

Also Published As

Publication number Publication date
IL257522B (en) 2020-04-30
JP6843120B2 (ja) 2021-03-17
HK1252212A1 (zh) 2019-05-24
NZ739993A (en) 2022-05-27
WO2017032678A1 (de) 2017-03-02
MX367959B (es) 2019-09-12
SG11201801378VA (en) 2018-03-28
TWI725044B (zh) 2021-04-21
RU2018109762A3 (hu) 2019-12-18
IL257522A (en) 2018-04-30
CA2995949A1 (en) 2017-03-02
CL2018000426A1 (es) 2018-07-20
EP3337801A1 (de) 2018-06-27
HRP20191476T1 (hr) 2019-11-15
EP3337801B1 (de) 2019-06-12
ZA201801867B (en) 2019-10-30
BR112018003334A2 (pt) 2018-09-18
KR20180043305A (ko) 2018-04-27
PT3337801T (pt) 2019-08-05
MX2018002236A (es) 2018-03-23
CN108137587A (zh) 2018-06-08
PL3337801T3 (pl) 2019-10-31
CO2018001759A2 (es) 2018-02-28
RS59086B1 (sr) 2019-09-30
TW201722943A (zh) 2017-07-01
UA124418C2 (uk) 2021-09-15
US20180244668A1 (en) 2018-08-30
SI3337801T1 (sl) 2019-08-30
AU2016311135B2 (en) 2020-09-10
CN108137587B (zh) 2020-10-23
LT3337801T (lt) 2019-08-12
UY36863A (es) 2017-03-31
JOP20160185B1 (ar) 2021-08-17
ES2739907T3 (es) 2020-02-04
AU2016311135C1 (en) 2022-10-13
US10392384B2 (en) 2019-08-27
RU2715226C2 (ru) 2020-02-26
PE20180555A1 (es) 2018-04-02
DK3337801T3 (da) 2019-08-19
RU2018109762A (ru) 2019-09-23
KR102677034B1 (ko) 2024-06-24
AU2016311135A1 (en) 2018-03-15
JP2018523697A (ja) 2018-08-23

Similar Documents

Publication Publication Date Title
HUE044678T2 (hu) Eljárás (4S)-4-(4-ciano-2-metoxifenil)-5-etoxi-2,8-dimetil-1,4-dihidro-1,6-naftiridin-3-karboxamid elõállítására és (4S)-4-(4-ciano-2-metoxifenil)-5-etoxi- 2,8-dimetil-1,4-dihidro-1-6-naftiridin-3-karboxamid visszanyerésére elektrokémiai módszerekkel
HUE051350T2 (hu) Eljárás (4S)-4-(4-ciano-2-metoxifenil)-5-etoxi-2,8-dimetil-1,4-dihidro-1,6-naftridin-3-karboxamid elõállítására és tisztítására gyógyászati hatóanyagként való alkalmazása céljából
ZA201708417B (en) (s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
LT3159409T (lt) Antiprasminė nukleorūgštis, skirta panaudoti diušeno raumenų distrofijos gydymui
PL3337800T3 (pl) Sposób wytwarzania (4S)-4-(4-cyjano-2-metoksyfenylo)-5-etoksy-2,8-dimetylo-1,4dihydro-1,6-naftyrydyno-3-karboksyamidu i jego oczyszczanie do zastosowania jako aktywny składnik farmaceutyczny
ZA201801947B (en) Compounds as dna probes, methods and applications thereof
HUE055449T2 (hu) Hosszú hatástartamú koagulációs faktorok és eljárások ezek elõállítására
HUE050550T2 (hu) Oldható instant kávé és eljárás elõállítására
HUE043316T2 (hu) Eljárás polimer karbodiimidek elõállítására céziumsók hozzáadásával, polimer karbodiimidek és ezek alkalmazása
EP3204395A4 (en) Novel precatalyst scaffolds for cross-coupling reactions, and methods of making and using same
HUE049339T2 (hu) Glikopirrolátot tartalmazó készítmény, eljárás és berendezés
GB2555748B (en) Novel form of isoxadifen-ethyl, process for preparation and use thereof
ZA201801865B (en) Method for the preparation of the metabolites of (4s)- and (4r)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide and the use thereof
DK3356329T3 (da) Fremgangsmåde til fremstilling af 1-(4-methansulfonyl-2-trifluormethylbenzyl)-2-methyl-1H-pyrrolo[2,3-B]pyridin-3-yleddikesyre
GB2559718B (en) Novel crystalline form of tribenuron-methyl, process for preparation and use thereof
HUE049284T2 (hu) Eljárás (S)-2-acetiloxipropionsav és származékai elõállítására
GB2561750B (en) Novel crystalline form of thifensulfuron-methyl, process for preparation and use thereof
DK3533791T3 (da) Fremgangsmåde til fremstilling af 3-methyl-2-thiophencarboxylsyre
GB201510967D0 (en) Fluorogenic amino acid derivatives, process of preparation thereof and methods of use
DK3303297T3 (da) Ny fremgangsmåde til fremstilling af ivabradinbase med høj renhed og salte deraf
GB201508280D0 (en) Analyte detection using nanopores
GB201500456D0 (en) Analyte detection using nanopores
GB201406580D0 (en) Nucleic Acid Sample preparation
TH1601001984A (th) วิธีสำหรับการทำบริสุทธิ์ของเซลล์เอพิธีเลียลที่มีรงควัตถุของเรตินา